MENU
Advertisement
Show Filters
Refine by Content Type
Refine by Year
Sort By:
Choose Sites to Search:
Gastric Embolization to Treat Obesity
The rationale behind this therapeutic option for obese patients.
By Michael Wolf, MD; Susie Park, MD; and Gary Siskin, MD, FSIR
Instylla’s Embrace HES Approved for Peripheral Arterial Bleeds
October 29, 2026—Instylla, Inc., a developer of resorbable embolics for peripheral vascular embolization, announced that the FDA has approved an expanded indication for the company’s Embrace hydrogel embolic system (HES) to include embolization of peripheral arterial bleeds in vessels ≤ 6 mm.
Embolization: Delivering Results
By Jafar Golzarian, MD
